Short Term Efficiency of Presurgical Vacuum Formed Nasoalveolar Molding Aligners in Infants With Bilateral Cleft Lip and Palate Compared With Grayson Acrylic Formed Nasoalveolar Molding Appliances.

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04966572
Collaborator
(none)
24
1
2
12.9
1.9

Study Details

Study Description

Brief Summary

Newborns with bilateral cleft lip/ palate will be treated pre-surgically by either presurgical vacuum-formed nasoalveolar molding aligners VF (NAM) or conventional Grayson acrylic formed nasoalveolar molding appliances in order to evaluate their effect on the maxillary arch.

Condition or Disease Intervention/Treatment Phase
  • Device: Presurgical vacuum formed nasoalveolar molding aligners
  • Device: Conventional Grayson acrylic formed nasoalveolar molding appliances
N/A

Detailed Description

The aim of this trial is to evaluate and compare the short-term effect of VF (NAM) aligners with conventional Grayson appliances at 2 stages T1 (Before NAM therapy), and T2 (After NAM therapy) as regards maxillary arch changes.

Newborns with Bilateral cleft lip/ palate will be allocated randomly into two groups: the first group will receive presurgical vacuum-formed nasoalveolar molding aligners while the second group will receive conventional Grayson acrylic formed nasoalveolar molding appliances. The follow-up period will be 4-6 months till surgical lip closure. The changes in the maxillary arch will be assessed by digital maxillary models.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
single blinded
Primary Purpose:
Treatment
Official Title:
Short Term Efficiency of Presurgical Vacuum Formed Nasoalveolar Molding Aligners in Infants With Bilateral Cleft Lip and Palate Compared With Conventional Grayson Acrylic Formed Nasoalveolar Molding Appliances: A Randomized Clinical Trial
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Mar 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Presurgical vacuum formed nasoalveolar molding aligners group

In this group, all patients will receive 1-2 VF-NAM aligners incorporated with palatal screw in addition to taping from day 1 for 4-6 Months with follow-up every 3 weeks

Device: Presurgical vacuum formed nasoalveolar molding aligners
at first visit, the infants will receive this appliance which is a maxillary vacuum plate incorporated with palatal screw, the infant's parents will be instructed to activate the screw and apply horizontal tap which will be placed at the base of nose in order to approximate lip segments and to change tape daily. After that, The infants will be recalled one week after the first visit to add the nasal stents into the appliance.

Experimental: conventional Grayson acrylic formed nasoalveolar molding appliances group

This group will receive conventional Grayson acrylic formed nasoalveolar molding appliances without taping except some cases, with follow up every week for activation.

Device: Conventional Grayson acrylic formed nasoalveolar molding appliances
at first visit, the infants will receive this appliance which is a maxillary acrylic plate without adding taping, the infants will be recalled bi weekly for activating the appliance. When the cleft alveolar gap is reduced to 6mm or less, a pair of nasal stents will be added to mold the nasal cartilage. the infants will be followed up for 4-6 months.

Outcome Measures

Primary Outcome Measures

  1. Changes in the maxillary arch [T1 and T2 (4- 6 months)]

    they will be measured in mm by digital models

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 1 Month
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Non-syndromic Infants with complete BCLP infants

  • Infants less than 1 month of age

  • Males and females.

  • Infants with displaced premaxilla

  • Patients whose parents provided written consent for the study.

Exclusion Criteria:
  • Patients above 1 month of age

  • Syndromic and systemically ill infants.

  • Patients with unilateral cleft lip and palate.

  • Incomplete Cleft lip.

  • Medically compromised patients

  • Patient's/guardians who will be unwilling to go through the PNAM therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo University Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Fatma Abdu Abdelsayed, Professor, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Khadega Ali Al Khateeb, Phd student, faculty of Dentistry, Cairo university, Cairo University
ClinicalTrials.gov Identifier:
NCT04966572
Other Study ID Numbers:
  • BCLP_ Grayson_ vacuum
First Posted:
Jul 19, 2021
Last Update Posted:
Jul 22, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2021